Vapor-Phase Hydrogen Peroxide Resistance of Environmental Isolates

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-08-02-2004
Volume 28
Issue 8

The authors examine the VHP resistance of microbial isolates recovered from controlled environments and compared them with commercially available biological indicators under various test conditions.

External Link - article-112218.pdf

Articles in this issue
Stable Isotopic Characterization of Analgesic Drugs
August 2004
Increased Outsourcing Driving Investments in CRO Industry
E-Health Information Campaign Shapes Pharmaceutical Regulation
Photosensitivity of Internal Standard Valerophenone Used in USP Ibuprofen Bulk Drug and Tablet Assay and Its Effect on the Quantitation of Ibuprofen and Its Impurities
In the Spotlight-August 2004
Interphex Delivers Packaging Solutions
Vapor-Phase Hydrogen Peroxide Resistance of Environmental Isolates
Decoding the US Pharmacopeia
Recent Videos
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Behind the Headlines episode 6
Behind the Headlines episode 5
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Feliza Mirasol
December 20th 2024
Article

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

AbbVie to Boost Immunology Pipeline with Acquisition of Nimble Therapeutics

Feliza Mirasol
December 18th 2024
Article

AbbVie's latest acquisition target is Nimble Therapeutics, which will give AbbVie a lead asset, an oral peptide for treating psoriasis.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Intertek Teams Up with CrystecPharma on Formulation and Development of Dry Powder Inhaler Products

Feliza Mirasol
December 13th 2024
Article

The partners will aim to establish a platform that enables rapid development of DPI products.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

GSK Enters into Strategic Collaborations with Relation and Muna to Advance Drug Development

Feliza Mirasol
December 12th 2024
Article

With these agreements, the respective parties will work to advance therapeutic candidates for treating fibrotic diseases, osteoarthritis, and Alzheimer’s disease.